Concepedia

Alexandra Hinniger

AH

Statistics

Publications

12

Citations

1.2K

H-Index

12

Active since

2011

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (China)

Alexandra Hinniger is an author at Novartis (Switzerland) specializing in life sciences, drug discovery, and molecular biology.

Publications per year

2011–2025

12

Publications

12

A simple protocol for amino acid type selective isotope labeling in insect cells with improved yields and high reproducibility

Alvar D. Gossert, Alexandra Hinniger, Sascha Gutmann et al. · Journal of Biomolecular NMR · 2011 · 483 citations

, , +10

Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Daniela Angst, F. Gessier, Philipp Janser et al. · Journal of Medicinal Chemistry · 2020 · 162 citations · Full text

, , +14

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition

Carien Dekker, Henri Mattes, Michael Wright et al. · Journal of Molecular Biology · 2021 · 160 citations

, , +16

Molecular basis for AU-rich element recognition and dimerization by the HuR C-terminal RRM

Nina Ripin, Julien Boudet, Małgorzata Duszczyk et al. · Proceedings of the National Academy of Sciences · 2019 · 116 citations · Full text

, , +16

PAX8 and MECOM are interaction partners driving ovarian cancer

Melusine Bleu, Fanny Mermet‐Meillon, Verena Apfel et al. · Nature Communications · 2021 · 82 citations · Full text

, , +17

1–5 of 12